TMCI
$1.24-0.07 (-5.34%)
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States.
Recent News
How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target Resets
Analysts have shifted their price targets on Treace Medical Concepts into a lower single digit range, with modelled fair value moving from US$4.20 to US$3.85 as part of a refreshed view on the stock. This reset lines up with a split narrative, where bullish voices highlight supportive Q4 data and perceived limited downside, while more cautious analysts point to execution risks and mixed product trends. As you read on, you will see how these differing views are shaping the evolving story...
Treace Medical Concepts, Inc. Q4 2025 Earnings Call Summary
Moby summary of Treace Medical Concepts, Inc.'s Q4 2025 earnings call
Treace Medical Concepts Inc (TMCI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
Despite a revenue dip, Treace Medical Concepts Inc (TMCI) focuses on product innovation and market expansion to drive future growth.
Treace Medical Concepts Q4 Earnings Call Highlights
Treace Medical Concepts (NASDAQ:TMCI) management told investors it is entering what it called a “transformational phase,” expanding beyond its historical Lapiplasty focus to become a broader “comprehensive bunion solutions company.” On the company’s fourth quarter and full-year 2025 earnings call, e
Treace Medical Concepts: Q4 Earnings Snapshot
The Ponte Vedra, Florida-based company said it had a loss of 15 cents per share. Losses, adjusted to extinguish debt, were 12 cents per share. The results beat Wall Street expectations.